Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
Go back to Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China| (AMEX: IVBIY) | Delayed: 54.29 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.29 | 52 Week High | $ | |||
| Open | $54.29 | 52 Week Low | $ | |||
| Day High | $54.29 | P/E | N/A | |||
| Day Low | $54.29 | EPS | $ | |||
| Volume | 14 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1183.46 +1.57 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1181.89 | 52 Week High | $88.16 | |||
| Open | $1185.32 | 52 Week Low | $67.88 | |||
| Day High | $1190.00 | P/E | 273.95 | |||
| Day Low | $1160.84 | EPS | $4.32 | |||
| Volume | 1,924,379 | |||||
